Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | +0.81% | +5.04% | +23.76% |
May. 15 | Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating | MT |
May. 14 | Passage Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 58
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Chou
CEO | Chief Executive Officer | 51 | 22-10-09 |
James M. Wilson
FOU | Founder | - | 17-06-30 |
Director of Finance/CFO | 48 | 21-10-31 | |
Mark Forman
CTO | Chief Tech/Sci/R&D Officer | 60 | 21-07-29 |
Andrea Campanile
CTO | Chief Tech/Sci/R&D Officer | - | - |
Alex Fotopoulos
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-06-30 |
Investor Relations Contact | - | 21-01-31 | |
Edgar Cale
LAW | General Counsel | 60 | 19-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Maxine Gowen
CHM | Chairman | 66 | 21-02-17 |
Saqib Islam
BRD | Director/Board Member | 54 | 19-03-28 |
Director/Board Member | 52 | 20-01-31 | |
Director/Board Member | 54 | 19-11-30 | |
Derrell Porter
BRD | Director/Board Member | 53 | 21-05-26 |
William Chou
CEO | Chief Executive Officer | 51 | 22-10-09 |
Dolan Sondhi
BRD | Director/Board Member | 53 | 23-07-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 61,640,596 | 61,339,949 ( 99.51 %) | 0 | 99.51 % |
Company contact information
Passage Bio, Inc.
One Commerce Square 2005 Market Street
19103, Philadelphia
+
http://www.passagebio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.76% | 76.43M | |
+16.73% | 123B | |
+13.04% | 107B | |
-5.80% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-14.00% | 16.23B | |
+1.18% | 13.43B | |
+24.18% | 11.32B |
- Stock Market
- Equities
- PASG Stock
- Company Passage Bio, Inc.